Tratamento de Doença Relacionada com IgG4 (IgG4 RD) em Istambul — receba 3 correspondências de clínicas personalizadas

Professor de Oncologia Médica com foco em Oncologia Gastrointestinal – o Prof. Sağlam traz experiência especializada em casos de IgG4 RD no Hospital Gayrettepe Florence Nightingale.

• Mais de 15 anos de experiência em oncologia médica
• Formação de fellowship na Universidade de Istambul – uma instituição médica de liderança
• Membro da ESMO e ASCO – principais sociedades de oncologia
• Especializado em oncologia gastrointestinal desde 2005

O Prof. Dr. Sefik Igdem é especialista em oncologia radioterápica avançada no Hospital Gayrettepe Florence Nightingale.

• Ter experiência no tratamento de cancros da cabeça e do pescoço
• Utilizar tecnologias avançadas como o Truebeam Stx
• Ser professor na Universidade T.R. Demiroğlu Bilim
• Especializar-se em tratamentos conformados para precisão

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.